Laurion Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-59,150	Closed	-$158K	–	473
2021 Q2	$158K	Sell	59,150 -222,982	-79%	-$596K	﹤0.01%	442
2021 Q1	$869K	Buy	+282,132	New	+$869K	﹤0.01%	316